Connection

Rolando Cimaz to Child

Back to Details
This is a "connection" page, showing publications Rolando Cimaz has written about Child.
Rolando Cimaz
Connection Strength
0.766
Child
  1. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review. Reumatismo. 2021 Apr 19; 73(1):48-53.
    View in: PubMed
    Score: 0.028
  2. Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members. Semin Arthritis Rheum. 2020 12; 50(6):1214-1215.
    View in: PubMed
    Score: 0.027
  3. Management of Juvenile idiopathic arthritis-associated uveitis duringthe COVID-19 pandemic in a pediatric referral center in Lombardy. Ocul Immunol Inflamm. 2020 Nov 16; 28(8):1305-1307.
    View in: PubMed
    Score: 0.027
  4. Should Coronavirus Disease 2019-Associated Inflammatory Syndromes in Children Affect Social Reintegration? JAMA Pediatr. 2020 09 01; 174(9):827-828.
    View in: PubMed
    Score: 0.027
  5. Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy. Paediatr Drugs. 2020 06; 22(3):263-264.
    View in: PubMed
    Score: 0.026
  6. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic. RMD Open. 2020 06; 6(2).
    View in: PubMed
    Score: 0.026
  7. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35.
    View in: PubMed
    Score: 0.026
  8. One year in review: Kawasaki disease. Curr Opin Rheumatol. 2020 01; 32(1):15-20.
    View in: PubMed
    Score: 0.026
  9. Evidence-Based Treatment for Uveitis. Isr Med Assoc J. 2019 Jul; 21(7):475-479.
    View in: PubMed
    Score: 0.025
  10. Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age. Int J Mol Sci. 2019 Jan 21; 20(2).
    View in: PubMed
    Score: 0.024
  11. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments. Clin Exp Rheumatol. 2018 Sep-Oct; 36(5):929-933.
    View in: PubMed
    Score: 0.023
  12. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration. Arthritis Care Res (Hoboken). 2018 07; 70(7):1046-1051.
    View in: PubMed
    Score: 0.023
  13. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J. 2017 Dec 21; 15(1):84.
    View in: PubMed
    Score: 0.022
  14. Joint pain management in children and adolescents. Minerva Pediatr. 2018 Feb; 70(1):79-97.
    View in: PubMed
    Score: 0.022
  15. Osteoporosis in childhood. Curr Opin Rheumatol. 2017 Sep; 29(5):535-546.
    View in: PubMed
    Score: 0.022
  16. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports. J Med Case Rep. 2017 Aug 16; 11(1):225.
    View in: PubMed
    Score: 0.022
  17. How I treat juvenile idiopathic arthritis: A state of the art review. Autoimmun Rev. 2017 Oct; 16(10):1008-1015.
    View in: PubMed
    Score: 0.022
  18. Physical Exercise and Physical Activity for Children and Adolescents With Juvenile Idiopathic Arthritis: A Literature Review. Pediatr Phys Ther. 2017 07; 29(3):256-260.
    View in: PubMed
    Score: 0.022
  19. Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records. Eur J Pediatr. 2017 Aug; 176(8):1061-1065.
    View in: PubMed
    Score: 0.022
  20. An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children. Paediatr Drugs. 2017 Jun; 19(3):165-172.
    View in: PubMed
    Score: 0.021
  21. Pediatric Osteoporosis: Diagnosis and Treatment Considerations. Drugs. 2017 Apr; 77(6):679-695.
    View in: PubMed
    Score: 0.021
  22. Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis. J Rheumatol. 2017 06; 44(6):822-826.
    View in: PubMed
    Score: 0.021
  23. Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone. Am J Case Rep. 2017 03 29; 18:317-319.
    View in: PubMed
    Score: 0.021
  24. Musculoskeletal pain in children, when hypermobility is the problem. Arch Pediatr. 2017 May; 24(5):421-423.
    View in: PubMed
    Score: 0.021
  25. Investigational drugs for treatment of juvenile idiopathic arthritis. Expert Opin Investig Drugs. 2017 Apr; 26(4):381-387.
    View in: PubMed
    Score: 0.021
  26. Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium. J Enzyme Inhib Med Chem. 2016; 31(sup4):60-63.
    View in: PubMed
    Score: 0.020
  27. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin Exp Rheumatol. 2010 Jan-Feb; 28(1 Suppl 57):93-7.
    View in: PubMed
    Score: 0.013
  28. [Update in pediatric rheumatology]. An Pediatr (Barc). 2005 Oct; 63(4):293-8.
    View in: PubMed
    Score: 0.010
  29. Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases. J Rheumatol. 2002 Aug; 29(8):1786-92.
    View in: PubMed
    Score: 0.008
  30. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021 Mar 16; 19(1):29.
    View in: PubMed
    Score: 0.007
  31. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics. Ital J Pediatr. 2021 Feb 08; 47(1):24.
    View in: PubMed
    Score: 0.007
  32. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. J Pediatr. 2020 Jul; 222:261-262.
    View in: PubMed
    Score: 0.007
  33. Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs. J Rheumatol. 2021 08; 48(8):1343-1344.
    View in: PubMed
    Score: 0.007
  34. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021 02; 80(2):e18.
    View in: PubMed
    Score: 0.007
  35. The protease systems and their pathogenic role in juvenile idiopathic arthritis. Autoimmun Rev. 2019 Aug; 18(8):761-766.
    View in: PubMed
    Score: 0.006
  36. Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings. J Med Case Rep. 2019 Apr 24; 13(1):104.
    View in: PubMed
    Score: 0.006
  37. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J. 2019 Feb 28; 17(1):10.
    View in: PubMed
    Score: 0.006
  38. Common symptoms for a rare disease in a girl with sarcoidosis: a case report. Ital J Pediatr. 2018 Jun 28; 44(1):74.
    View in: PubMed
    Score: 0.006
  39. The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series. Autoimmun Rev. 2018 Aug; 17(8):768-774.
    View in: PubMed
    Score: 0.006
  40. Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study. Clin Rheumatol. 2018 Aug; 37(8):2233-2240.
    View in: PubMed
    Score: 0.006
  41. The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int. 2018 Apr; 38(Suppl 1):251-258.
    View in: PubMed
    Score: 0.006
  42. Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach. Semin Arthritis Rheum. 2018 12; 48(3):495-503.
    View in: PubMed
    Score: 0.006
  43. Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations. Clin Rheumatol. 2018 May; 37(5):1407-1411.
    View in: PubMed
    Score: 0.006
  44. Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA). Ann Rheum Dis. 2018 10; 77(10):1426-1431.
    View in: PubMed
    Score: 0.006
  45. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. Rheumatology (Oxford). 2018 01 01; 57(1):100-111.
    View in: PubMed
    Score: 0.006
  46. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series. Am J Ophthalmol. 2018 03; 187:158-166.
    View in: PubMed
    Score: 0.005
  47. Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey. Pediatr Rheumatol Online J. 2017 Aug 07; 15(1):61.
    View in: PubMed
    Score: 0.005
  48. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2017 May; 76(5):782-791.
    View in: PubMed
    Score: 0.005
  49. Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary. Pediatr Infect Dis J. 2017 04; 36(4):440-441.
    View in: PubMed
    Score: 0.005
  50. Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis. Indian J Pediatr. 2017 Apr; 84(4):294-298.
    View in: PubMed
    Score: 0.005
  51. Kawasaki's disease in northern Italy: a multicenter retrospective study of 250 patients. Clin Exp Rheumatol. 2002 May-Jun; 20(3):421-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.